Clinical Psychology Service, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90127 Palermo, Italy.
Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90127 Palermo, Italy.
Int J Environ Res Public Health. 2020 May 27;17(11):3809. doi: 10.3390/ijerph17113809.
This study aims to investigate the quality of life and the therapeutic compliance of the patients who received a liver transplant, from a living or deceased donor, at IRCCS ISMETT in the last three years. Liver transplantation is an effective therapeutic strategy for patients with end-stage liver failure. The quality of life (QOL) of liver disease patients is placed under considerable stress due to the debilitating clinical conditions and related issues experienced in everyday life by these individuals. The concept of QOL is being increasingly used to define the individual perception of health, including physical, mental, and social wellbeing. The success of a liver transplant should therefore be intended not only in terms of survival, but also of recovery of a satisfying quality of life. For this reason, our liver transplant recipients are closely monitored and supported from a psychological standpoint. This is done to monitor their ability to adapt to and comply with their clinical condition and to verify their gradual resumption of their path of life Methods: We retrospectively analyzed data collected by the IRCCS ISMETT Clinical Psychology Service during routine psychological follow-up of liver transplant recipients. Data refer to 82 patients who received a liver transplant between January 2017 and September 2019 and describe their QOL and therapeutic adherence. The obtained results were compared with the main studies on this issue available in literature.
Ninety-four percent of liver transplant recipients reported high mean scores of quality of life and therapeutic adherence 28% of patients reported at least one persistent annoying symptom after transplantation, although in some cases this did not affect the overall QOL. The results also refer to patients with a pre-transplant diagnosis of alcohol-related cirrhosis, who confirm their complete abstinence from alcohol.
Our results confirm the efficacy of the liver transplantation to achieve of a good QOL. Furthermore, these patients seem to maintain high therapeutic adherence, thus ensuring a good outcome of the care received during the transplantation process.
本研究旨在调查过去三年在 IRCCS ISMETT 接受活体或已故供体肝移植的患者的生活质量和治疗依从性。肝移植是治疗终末期肝功能衰竭患者的有效治疗策略。由于这些患者在日常生活中经历的衰弱的临床状况和相关问题,肝病患者的生活质量(QOL)受到了相当大的压力。QOL 的概念越来越多地被用来定义个人对健康的感知,包括身体、心理和社会幸福感。因此,肝移植的成功不仅应体现在存活方面,还应体现在恢复令人满意的生活质量方面。出于这个原因,我们的肝移植受者从心理角度得到密切监测和支持。这样做是为了监测他们适应和遵守临床状况的能力,并验证他们逐渐恢复生活道路的能力。
我们回顾性分析了 IRCCS ISMETT 临床心理学服务在肝移植受者常规心理随访过程中收集的数据。数据涉及 2017 年 1 月至 2019 年 9 月期间接受肝移植的 82 名患者,描述了他们的生活质量和治疗依从性。所得结果与文献中关于这一问题的主要研究进行了比较。
94%的肝移植受者报告生活质量和治疗依从性的平均得分较高,28%的患者报告移植后至少有一个持续的烦扰症状,但在某些情况下,这并未影响整体 QOL。结果还涉及有酒精性肝硬化移植前诊断的患者,他们确认完全戒酒。
我们的结果证实了肝移植实现良好 QOL 的功效。此外,这些患者似乎保持了较高的治疗依从性,从而确保了在移植过程中接受的护理的良好结果。